Literature DB >> 12875956

Acute psychosis associated with levetiracetam.

Sotiris Youroukos1, Despina Lazopoulou, Danae Michelakou, Joanna Karagianni.   

Abstract

A twelve year-old-girl with idiopathic partial epilepsy with secondary generalization, developed acute psychosis 10 days after the administration of levetiracetam. The patient was already on sodium valproate, and levetiracetam was given as add on therapy. A final dosage of 60 mg/kg was used. Complete seizure control was achieved but the patient developed hallucinations, agitation and self-harming behaviour, as well as poor social contact. The psychotic behavior resolved completely soon after the discontinuation of levetiracetam.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875956

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  11 in total

Review 1.  Benefit-risk assessment of levetiracetam in the treatment of partial seizures.

Authors:  Bassel Abou-Khalil
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

3.  Acute mania associated with levetiracetam treatment.

Authors:  Eliza M Park; Jordan A Holmes; Katherine E Reeder-Hayes
Journal:  Psychosomatics       Date:  2013-08-09       Impact factor: 2.386

4.  Levetiracetam-induced acute psychosis in a child.

Authors:  Syed Ahmed Zaki; Saurabh Gupta
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

5.  Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.

Authors:  Nithin Kumar; H S Swaroop; Ananya Chakraborty; Suhas Chandran
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

6.  Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age.

Authors:  Justine Cormier; Catherine J Chu
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-21       Impact factor: 2.570

7.  Acute psychosis with a favorable outcome as a complication of central pontine/extrapontine myelinolysis in a middle aged man.

Authors:  Rishab Gupta; Yatan Pal Singh Balhara; Rajesh Sagar
Journal:  J Midlife Health       Date:  2012-07

8.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

Review 9.  Clinical pharmacology and pharmacokinetics of levetiracetam.

Authors:  Chanin Wright; Jana Downing; Diana Mungall; Owais Khan; Amanda Williams; Ekokobe Fonkem; Darin Garrett; Jose Aceves; Batool Kirmani
Journal:  Front Neurol       Date:  2013-12-04       Impact factor: 4.003

10.  Levetiracetam induced hypomania: a case report.

Authors:  Ali Ercan Altınöz; Şengül Tosun Altınöz; Başak Güzel Biltekin; Murat Can Kaya
Journal:  Ther Adv Drug Saf       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.